Making Virus Inactivation a Reality for Continuous Upscaled Processes

The Cadence™ Virus Inactivation (VI) system, a fully automated low pH virus inactivation system for both batch and continuous processing is one of the latest additions to Pall’s Continuous platform.  This webinar will discuss how traditional low pH virus inactivation has been translated into an automatic system, and also the additional challenges associated with making it a continuous process.  There will be a review of the two methods used for validating the design and an overview of the integration of capture chromatography and virus inactivation, which represents the first commercial scale combined unit operations in this space.

 

Moderator

David Johnson

 

Senior Global Product Manager, Continuous Purification

Pall

Speakers

Mark Schofield, Ph.D.

 

Principal R&D Engineer
Pall

Biography

Making Virus Inactivation a Reality for Continuous Upscaled Processes

Download our eBook on Virus Safety

More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
October 2022
Learning From the Pandemic: Rapid Scale-up of Manufacturing Processes Enabled by Industry Collaboration

Biotech Research & Commercialization Solutions | Pall Corporation webinar series

How Pall and Oxford Biomedica collaborated to develop and scale-up the manufacturing process for the ChAdOx1 COVID-19 vaccine enabling Oxford Biomedica to start manufacturing in less than 6 months.

 

Date & Time:

Thursday October 20, 2022 | 07:00 PST| 10:00 EST | 15:00 BST | 16:00 CET

 

Watch